Cargando…

High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study

BACKGROUND: Although drug trials with niacin and cholesteryl ester transfer protein inhibitors that substantially increase high-density lipoprotein-cholesterol (HDL-C) failed to reduce the risk of coronary heart disease, HDL protection of the cardiovascular system cannot be easily denied. Hence, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fan, Wang, Xiaona, Ye, Ping, Cao, Ruihua, Zhang, Yun, Qi, Yue, Zhao, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756332/ https://www.ncbi.nlm.nih.gov/pubmed/29304861 http://dx.doi.org/10.1186/s12944-017-0650-z

Ejemplares similares

Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study
por: Wang, Xiaona, et al.
Publicado: (2016)

Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population
por: Wang, Xiaona, et al.
Publicado: (2021)

The association between Hepcidin and arterial stiffness in a community-dwelling population
por: Wang, Xiaona, et al.
Publicado: (2018)

Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population
por: Wen, Jia, et al.
Publicado: (2019)

A higher baseline plasma uric acid level is an independent predictor of arterial stiffness: A community-based prospective study
por: Ding, Xiao-Han, et al.
Publicado: (2017)

Peripheral arterial stiffness is associated with higher baseline plasma uric acid: A prospective cohort study
por: Ding, Xiaohan, et al.
Publicado: (2017)

Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period
por: Li, Gang, et al.
Publicado: (2018)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

Association between serum uric acid to high density lipoprotein-cholesterol ratio and arterial stiffness in a Japanese population
por: Wang, Haidong, et al.
Publicado: (2023)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects
por: Zhu, Chen, et al.
Publicado: (2022)

Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study
por: Wang, Xiao-rong, et al.
Publicado: (2018)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2017)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

The predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function
por: Han, Jie, et al.
Publicado: (2016)

Association of High-Density Lipoprotein Cholesterol with the Estimated Glomerular Filtration Rate in a Community-Based Population
por: Wang, Fan, et al.
Publicado: (2013)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
por: Jafari, Jamal, et al.
Publicado: (2019)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes
por: Mayasari, Dyah Samti, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol
por: Wang, Yi-Kai, et al.
Publicado: (2022)

Polygenic determinants in extremes of high-density lipoprotein cholesterol
por: Dron, Jacqueline S., et al.
Publicado: (2017)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Association Between Cumulative Exposure to Increased Low-Density Lipoprotein Cholesterol and the New Occurrence of Peripheral Artery Disease
por: Liu, Xinmin, et al.
Publicado: (2021)

Association between High-density-lipoprotein-cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis
por: Li, Xin, et al.
Publicado: (2017)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

High-density lipoprotein cholesterol levels is negatively associated with intertrochanter bone mineral density in adults aged 50 years and older
por: Yang, Pei, et al.
Publicado: (2023)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i3oud8covh9dkfj94s4fepj8s1